- Cytology
- Cystoscopy
- Urologic Oncology
- Artificial Intelligence (AI)
- Cytopathology
- Non-Muscle Invasive Bladder Cancer (NMIBC)
- 2025 NMIBC Creator Weekend™
- Blue Light Cystoscopy
- Bladder Cancer
How are leading urologic oncologists using advanced biomarkers and artificial intelligence to refine the diagnosis and management of non-muscle invasive bladder cancer (NMIBC)? In the opening episode of our 2025 NMIBC Creator Weekend™ series, host Dr. Bogdana Schmidt engages in an insightful, in-studio discussion with Dr. Anne Schuckman and Dr. Piyush Agarwal about contemporary strategies and challenges in the diagnosis of non-muscle invasive bladder cancer.
This podcast is supported by
Timestamps
Resources
More about this episode
The doctors emphasize the importance of having an experienced cytopathologist and discuss the use of different biomarkers and imaging modalities in bladder cancer diagnosis. The conversation delves into risk stratification, patient management strategies, and the evolving role of technology and artificial intelligence in enhancing diagnostic accuracy. The experts also share their perspectives on future advancements and their potential impact on clinical practice.


